Home / Latest Reports / Anticoagulants Market

Anticoagulants Market by Drug Category, Application, End User, Key Players and Regions - Global Industry Analysis & Forecast to 2027

Published On : August 2022 Pages : 185 Category: Medical Devices Report Code : HC0817768

Request Sample Inquiry Before Buying Request for Customization Check Discount

The global Anticoagulants Market is valued at USD XX billion in 2021 and is projected to reach USD XX billion by the end of 2027, growing at a CAGR of XX% during the period 2022 to 2027.

The report exhibit detail coverage of Anticoagulants industry and market trends. The report also analyses present and past market values to forecast potential market through the forecast period between 2022-2027. This research study of Anticoagulants Market involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

In addition, the report provides insight into main drivers, challenges, opportunities and risk of the market and strategies of suppliers. Key players are profiled as well. Overall, this report covers the historical situation, present status and the future prospects of the global Anticoagulants Market for 2017-2027.

Crystal Market Research envisions that the span of the Anticoagulants Market will develop amid the estimated time frame as the Compound Annual Growth Rate boosts significantly. The objective of the market research report is the current status of the market and in accordance classifies it into a few portions. The report takes into consideration the prime market players in every area from over the globe.

Our research study analyses the size of the global market of Anticoagulants in primary regions such as North America, South America, Middle East & Africa, Asia Pacific and Europe. It also classifies the Anticoagulants Market by key manufacturers, region, type and application. Furthermore, this study examines in the status of the market, market share, future trends, growth rate, competitive landscape, opportunities, market driving factors and restraints, and challenges.

To stay updated with the latest technology and functions of the industry, Crystal Market Research regularly performs interviews with several industry experts and visits for its expert research analysts. The data sources include but not limited to reports of company’s, international organizations and governments, MMI market surveys, and related industry news.

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2017 to 2027. This report has segmented the Anticoagulants Market on the basis of type, application, and region:

Competitive Analysis                    

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Bristol-Myers Squibb
  • Bayer AG
  • Boehringer Ingelheim
  • Johnson and Johnson
  • Daiichi Sankyo Company
  • Amphastar Pharmaceuticals, Inc.
  • Sanofi
  • Shenzhen Hepalink
  • Pfizer
  • Leo Pharma
  • Rovi
  • United Therapeutics

By Drug Category

  • Heparins
  • Factor Xa inhibitor
  • Warfarin (Vitamin K antagonist)
  • Direct Thrombin Inhibitor
  • Others

By Application

  • Atrial Fibrillation/Flutter
  • Venous Thromboembolism
  • Coronary Heart Disease
  • Others

By

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Region

  • North America (US, Canada)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Mexico, Columbia, Rest of South America)
  • Middle East and Africa (Saudi Arabia, UAE, South Africa, Turkey, Rest of MEA)

Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2022 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Table of Contents

1.     Introduction

1.1.  Report Description

1.2.  Research Methodology

1.2.1.     Data Mining

1.2.2.     Market Modeling and Forecasting

1.2.3.     Data Validation

1.2.4.     Industry Analysis

2.     Market Dashboard

3.     Market Overview

3.1.  Introduction

3.1.1.     Market Definition

3.1.2.     Market Segmentation

3.2.  Market Dynamics

3.2.1.     Drivers

3.2.2.     Restraints

3.2.3.     Opportunities

3.2.4.     Challenges

4.     Anticoagulants Market, By Drug Category

4.1.  Introduction

4.2.  Anticoagulants Market Size and Growth Rate By Drug Category (2017-2022)

4.3.  Heparins

4.3.1.     Global Heparins Market Size and Growth Rate (2017-2022)

4.4.  Factor Xa inhibitor

4.4.1.     Global Factor Xa inhibitor Market Size and Growth Rate (2017-2022)

4.5.  Warfarin (Vitamin K antagonist)

4.5.1.     Global Warfarin (Vitamin K antagonist) Market Size and Growth Rate (2017-2022)

4.6.  Direct Thrombin Inhibitor

4.6.1.     Global Direct Thrombin Inhibitor Market Size and Growth Rate (2017-2022)

4.7.  Others

4.7.1.     Global Others Market Size and Growth Rate (2017-2022)

5.     Anticoagulants Market, By Application

5.1.  Introduction

5.2.  Anticoagulants Market Size and Growth Rate By Application (2017-2022)

5.3.  Atrial Fibrillation/Flutter

5.3.1.     Global Atrial Fibrillation/Flutter Market Size and Growth Rate (2017-2022)

5.4.  Venous Thromboembolism

5.4.1.     Global Venous Thromboembolism Market Size and Growth Rate (2017-2022)

5.5.  Coronary Heart Disease

5.5.1.     Global Coronary Heart Disease Market Size and Growth Rate (2017-2022)

5.6.  Others

5.6.1.     Global Others Market Size and Growth Rate (2017-2022)

6.     Anticoagulants Market, By

6.1.  Introduction

6.2.  Anticoagulants Market Size and Growth Rate By (2017-2022)

6.3.  Hospital Pharmacy

6.3.1.     Global Hospital Pharmacy Market Size and Growth Rate (2017-2022)

6.4.  Retail Pharmacy

6.4.1.     Global Retail Pharmacy Market Size and Growth Rate (2017-2022)

6.5.  Online Pharmacy

6.5.1.     Global Online Pharmacy Market Size and Growth Rate (2017-2022)

7.     Anticoagulants Market, By Region

7.1.  Introduction

7.2.  Anticoagulants Market Size and Growth Rate By Regions

7.2  North America

7.2.1.     North America Anticoagulants Market Size and Growth Rate (2017-2022))

7.2.2.     North America Anticoagulants Market By Drug Category (2017-2022)

7.2.3.     North America Anticoagulants Market By Application (2017-2022)

7.2.4.     North America Anticoagulants Market By (2017-2022)

7.2.5.     North America Anticoagulants Market By Country (2017-2022)

7.2.6.     United States

7.2.6.1.United States Anticoagulants Market Size and Growth Rate (2017-2022)

7.2.6.2.United States Anticoagulants Market By Drug Category (2017-2022)

7.2.6.3.United States Anticoagulants Market By Application (2017-2022)

7.2.6.4.United States Anticoagulants Market By (2017-2022)

7.2.7.     Canada

7.2.7.1.Canada Anticoagulants Market Size and Growth Rate (2017-2022)

7.2.7.2.Canada Anticoagulants Market By Drug Category (2017-2022)

7.2.7.3.Canada Anticoagulants Market By Application (2017-2022)

7.2.7.4.Canada Anticoagulants Market By (2017-2022)

7.3  Europe

7.3.1.     Europe Anticoagulants Market Size and Growth Rate (2017-2022))

7.3.2.     Europe Anticoagulants Market By Drug Category (2017-2022)

7.3.3.     Europe Anticoagulants Market By Application (2017-2022)

7.3.4.     Europe Anticoagulants Market By (2017-2022)

7.3.5.     Europe Anticoagulants Market By Country (2017-2022)

7.3.6.     Germany

7.3.6.1.Germany Anticoagulants Market Size and Growth Rate (2017-2022)

7.3.6.2.Germany Anticoagulants Market By Drug Category (2017-2022)

7.3.6.3.Germany Anticoagulants Market By Application (2017-2022)

7.3.6.4.Germany Anticoagulants Market By (2017-2022)

7.3.7.     France

7.3.7.1.France Anticoagulants Market Size and Growth Rate (2017-2022)

7.3.7.2.France Anticoagulants Market By Drug Category (2017-2022)

7.3.7.3.France Anticoagulants Market By Application (2017-2022)

7.3.7.4.France Anticoagulants Market By (2017-2022)

7.3.8.     UK

7.3.8.1.UK Anticoagulants Market Size and Growth Rate (2017-2022)

7.3.8.2.UK Anticoagulants Market By Drug Category (2017-2022)

7.3.8.3.UK Anticoagulants Market By Application (2017-2022)

7.3.8.4.UK Anticoagulants Market By (2017-2022)

7.3.9.     Russia

7.3.9.1.Russia Anticoagulants Market Size and Growth Rate (2017-2022)

7.3.9.2.Russia Anticoagulants Market By Drug Category (2017-2022)

7.3.9.3.Russia Anticoagulants Market By Application (2017-2022)

7.3.9.4.Russia Anticoagulants Market By (2017-2022)

7.3.10.     Italy

7.3.10.1.Italy Anticoagulants Market Size and Growth Rate (2017-2022)

7.3.10.2.Italy Anticoagulants Market By Drug Category (2017-2022)

7.3.10.3.Italy Anticoagulants Market By Application (2017-2022)

7.3.10.4.Italy Anticoagulants Market By (2017-2022)

7.3.11.     Rest of Europe

7.3.11.1.Rest of Europe Anticoagulants Market Size and Growth Rate (2017-2022)

7.3.11.2.Rest of Europe Anticoagulants Market By Drug Category (2017-2022)

7.3.11.3.Rest of Europe Anticoagulants Market By Application (2017-2022)

7.3.11.4.Rest of Europe Anticoagulants Market By (2017-2022)

7.4  Asia-Pacific

7.4.1.     Asia-Pacific Anticoagulants Market Size and Growth Rate (2017-2022))

7.4.2.     Asia-Pacific Anticoagulants Market By Drug Category (2017-2022)

7.4.3.     Asia-Pacific Anticoagulants Market By Application (2017-2022)

7.4.4.     Asia-Pacific Anticoagulants Market By (2017-2022)

7.4.5.     Asia-Pacific Anticoagulants Market By Country (2017-2022)

7.4.6.     China

7.4.6.1.China Anticoagulants Market Size and Growth Rate (2017-2022)

7.4.6.2.China Anticoagulants Market By Drug Category (2017-2022)

7.4.6.3.China Anticoagulants Market By Application (2017-2022)

7.4.6.4.China Anticoagulants Market By (2017-2022)

7.4.7.     Japan

7.4.7.1.Japan Anticoagulants Market Size and Growth Rate (2017-2022)

7.4.7.2.Japan Anticoagulants Market By Drug Category (2017-2022)

7.4.7.3.Japan Anticoagulants Market By Application (2017-2022)

7.4.7.4.Japan Anticoagulants Market By (2017-2022)

7.4.8.     Korea

7.4.8.1.Korea Anticoagulants Market Size and Growth Rate (2017-2022)

7.4.8.2.Korea Anticoagulants Market By Drug Category (2017-2022)

7.4.8.3.Korea Anticoagulants Market By Application (2017-2022)

7.4.8.4.Korea Anticoagulants Market By (2017-2022)

7.4.9.     India

7.4.9.1.India Anticoagulants Market Size and Growth Rate (2017-2022)

7.4.9.2.India Anticoagulants Market By Drug Category (2017-2022)

7.4.9.3.India Anticoagulants Market By Application (2017-2022)

7.4.9.4.India Anticoagulants Market By (2017-2022)

7.4.10.     Southeast Asia

7.4.10.1.Southeast Asia Anticoagulants Market Size and Growth Rate (2017-2022)

7.4.10.2.Southeast Asia Anticoagulants Market By Drug Category (2017-2022)

7.4.10.3.Southeast Asia Anticoagulants Market By Application (2017-2022)

7.4.10.4.Southeast Asia Anticoagulants Market By (2017-2022)

7.4.11.     Rest of Asia-Pacific

7.4.11.1.Rest of Asia-Pacific Anticoagulants Market Size and Growth Rate (2017-2022)

7.4.11.2.Rest of Asia-Pacific Anticoagulants Market By Drug Category (2017-2022)

7.4.11.3.Rest of Asia-Pacific Anticoagulants Market By Application (2017-2022)

7.4.11.4.Rest of Asia-Pacific Anticoagulants Market By (2017-2022)

7.5  South America

7.5.1.     South America Anticoagulants Market Size and Growth Rate (2017-2022))

7.5.2.     South America Anticoagulants Market By Drug Category (2017-2022)

7.5.3.     South America Anticoagulants Market By Application (2017-2022)

7.5.4.     South America Anticoagulants Market By (2017-2022)

7.5.5.     South America Anticoagulants Market By Country (2017-2022)

7.5.6.     Brazil

7.5.6.1.Brazil Anticoagulants Market Size and Growth Rate (2017-2022)

7.5.6.2.Brazil Anticoagulants Market By Drug Category (2017-2022)

7.5.6.3.Brazil Anticoagulants Market By Application (2017-2022)

7.5.6.4.Brazil Anticoagulants Market By (2017-2022)

7.5.7.     Mexico

7.5.7.1.Mexico Anticoagulants Market Size and Growth Rate (2017-2022)

7.5.7.2.Mexico Anticoagulants Market By Drug Category (2017-2022)

7.5.7.3.Mexico Anticoagulants Market By Application (2017-2022)

7.5.7.4.Mexico Anticoagulants Market By (2017-2022)

7.5.8.     Columbia

7.5.8.1.Columbia Anticoagulants Market Size and Growth Rate (2017-2022)

7.5.8.2.Columbia Anticoagulants Market By Drug Category (2017-2022)

7.5.8.3.Columbia Anticoagulants Market By Application (2017-2022)

7.5.8.4.Columbia Anticoagulants Market By (2017-2022)

7.5.9.     Rest of South America

7.5.9.1.Rest of South America Anticoagulants Market Size and Growth Rate (2017-2022)

7.5.9.2.Rest of South America Anticoagulants Market By Drug Category (2017-2022)

7.5.9.3.Rest of South America Anticoagulants Market By Application (2017-2022)

7.5.9.4.Rest of South America Anticoagulants Market By (2017-2022)

7.6  Middle East and Africa

7.6.1.     Middle East and Africa Anticoagulants Market Size and Growth Rate (2017-2022))

7.6.2.     Middle East and Africa Anticoagulants Market By Drug Category (2017-2022)

7.6.3.     Middle East and Africa Anticoagulants Market By Application (2017-2022)

7.6.4.     Middle East and Africa Anticoagulants Market By (2017-2022)

7.6.5.     Middle East and Africa Anticoagulants Market By Country (2017-2022)

7.6.6.     Saudi Arabia

7.6.6.1.Saudi Arabia Anticoagulants Market Size and Growth Rate (2017-2022)

7.6.6.2.Saudi Arabia Anticoagulants Market By Drug Category (2017-2022)

7.6.6.3.Saudi Arabia Anticoagulants Market By Application (2017-2022)

7.6.6.4.Saudi Arabia Anticoagulants Market By (2017-2022)

7.6.7.     United Arab Emirates

7.6.7.1.United Arab Emirates Anticoagulants Market Size and Growth Rate (2017-2022)

7.6.7.2.United Arab Emirates Anticoagulants Market By Drug Category (2017-2022)

7.6.7.3.United Arab Emirates Anticoagulants Market By Application (2017-2022)

7.6.7.4.United Arab Emirates Anticoagulants Market By (2017-2022)

7.6.8.     South Africa

7.6.8.1.South Africa Anticoagulants Market Size and Growth Rate (2017-2022)

7.6.8.2.South Africa Anticoagulants Market By Drug Category (2017-2022)

7.6.8.3.South Africa Anticoagulants Market By Application (2017-2022)

7.6.8.4.South Africa Anticoagulants Market By (2017-2022)

7.6.9.     Rest of Middle East and Africa

7.6.9.1.Rest of Middle East and Africa Anticoagulants Market Size and Growth Rate (2017-2022)

7.6.9.2.Rest of Middle East and Africa Anticoagulants Market By Drug Category (2017-2022)

7.6.9.3.Rest of Middle East and Africa Anticoagulants Market By Application (2017-2022)

7.6.9.4.Rest of Middle East and Africa Anticoagulants Market By (2017-2022)

8.     Company Profiles

8.1.  Bristol-Myers Squibb

8.1.1.     Business Overview

8.1.2.     Service Portfolio

8.1.3.     Strategic Developments

8.1.4.     Financial Overview

8.2.  Bayer AG

8.2.1.     Business Overview

8.2.2.     Service Portfolio

8.2.3.     Strategic Developments

8.2.4.     Financial Overview

8.3.  Boehringer Ingelheim

8.3.1.     Business Overview

8.3.2.     Service Portfolio

8.3.3.     Strategic Developments

8.3.4.     Financial Overview

8.4.  Johnson and Johnson

8.4.1.     Business Overview

8.4.2.     Service Portfolio

8.4.3.     Strategic Developments

8.4.4.     Financial Overview

8.5.  Daiichi Sankyo Company

8.5.1.     Business Overview

8.5.2.     Service Portfolio

8.5.3.     Strategic Developments

8.5.4.     Financial Overview

8.6.  Amphastar Pharmaceuticals, Inc.

8.6.1.     Business Overview

8.6.2.     Service Portfolio

8.6.3.     Strategic Developments

8.6.4.     Financial Overview

8.7.  Sanofi

8.7.1.     Business Overview

8.7.2.     Service Portfolio

8.7.3.     Strategic Developments

8.7.4.     Financial Overview

8.8.  Shenzhen Hepalink

8.8.1.     Business Overview

8.8.2.     Service Portfolio

8.8.3.     Strategic Developments

8.8.4.     Financial Overview

8.9.  Pfizer

8.9.1.     Business Overview

8.9.2.     Service Portfolio

8.9.3.     Strategic Developments

8.9.4.     Financial Overview

8.10.  Leo Pharma

8.10.1.     Business Overview

8.10.2.     Service Portfolio

8.10.3.     Strategic Developments

8.10.4.     Financial Overview

8.11.  Rovi

8.11.1.     Business Overview

8.11.2.     Service Portfolio

8.11.3.     Strategic Developments

8.11.4.     Financial Overview

8.12.  United Therapeutics

8.12.1.     Business Overview

8.12.2.     Service Portfolio

8.12.3.     Strategic Developments

8.12.4.     Financial Overview

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2027)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*